REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 171 filers reported holding REGENXBIO INC in Q4 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $113,000 | -93.8% | 2,690 | -94.2% | 0.00% | -93.8% |
| Q2 2021 | $1,814,000 | +13.9% | 46,690 | 0.0% | 0.03% | +23.1% |
| Q1 2021 | $1,593,000 | +575.0% | 46,690 | +797.9% | 0.03% | +550.0% |
| Q4 2020 | $236,000 | +65.0% | 5,200 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $143,000 | -25.5% | 5,200 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $192,000 | +14.3% | 5,200 | 0.0% | 0.00% | -20.0% |
| Q1 2020 | $168,000 | -21.1% | 5,200 | 0.0% | 0.01% | +25.0% |
| Q4 2019 | $213,000 | +15.1% | 5,200 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $185,000 | 0.0% | 5,200 | +44.4% | 0.00% | 0.0% |
| Q2 2019 | $185,000 | -10.2% | 3,600 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $206,000 | -51.3% | 3,600 | -50.0% | 0.00% | -20.0% |
| Q4 2018 | $423,000 | +55.5% | 7,200 | +100.0% | 0.01% | -16.7% |
| Q3 2018 | $272,000 | – | 3,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |